510(k) K780335
K780335 is an FDA 510(k) premarket notification submitted by Hyland Therapeutic Div., Travenol Laboratories for the device "LAS-R HUMAN C1 ESTERASE INHIBITOR TEST". The FDA issued a decision of Substantially Equivalent on March 22, 1978. The device falls under product code DBA (Complement C1 Inhibitor (Inactivator), Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5250. Hyland Therapeutic Div., Travenol Laboratories has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 22, 1978
- Date Received
- February 28, 1978
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Complement C1 Inhibitor (Inactivator), Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5250
- Review Panel
- IM
- Submission Type